Dr. Omolara M. Olowoyeye, MD

Dr. Olowoyeye practices at Bethesda Endoscopy Center in Bethesda, Maryland.

Dr. Olowoyeye's NPI, 1760703193, was assigned on June 21, 2010. Dr. Olowoyeye holds Maryland license D81771.

Dr. Olowoyeye's primary practice is Bethesda Endoscopy Center, at 10215 Fernwood Rd, Bethesda, MD 20817 in Montgomery County. The practice phone is (301) 530-2800.

Dr. Olowoyeye's primary practice is Bethesda Endoscopy Center in Bethesda, Maryland. Dmand AI also links Dr. Olowoyeye to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olowoyeye practices. Vendor and product names are available with a free account.

Dermatology is Dr. Olowoyeye's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Olowoyeye is licensed in Maryland.

CMS data shows 158 Medicare services from Dr. Olowoyeye across 5 procedure codes in 2024, for 69 Medicare patients. Medicare paid $14,115 for them. Every service was in an office.

CMS counts 69 Medicare patients who saw Dr. Olowoyeye in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Olowoyeye's median patient age at 41, with 63% women.

In 2024, Dr. Olowoyeye wrote 177 Medicare Part D claims for 64 patients. 86% of them were for generic drugs. CMS names the drug for 105 of them, across 6 drugs with 11 or more claims each, at $4,065 in total drug cost. In 2023, CMS named 141 claims across 7 drugs.

Dr. Olowoyeye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 89 procedures of removal of skin lesions by Dr. Olowoyeye, more than 75% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Olowoyeye, published from 2016 to 2017. 2017 was the busiest year, with 2. Dr. Olowoyeye's most frequent co-authors are Ginette A. Okoye, MD, Anna L. Chien, MD and Tamia Alisha Harris-Tryon, MD, PhD.

CMS Open Payments shows 41 general payments to Dr. Olowoyeye from 16 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. Eli Lilly and Company paid the most, $373.